Hormone Therapy in the Era of the COVID-19 Pandemic:A Review

Author: Sung Wook CHOI ¹ ; Juhee KIM ; Jae Hoon LEE ; Seul Ki KIM ; Sa Ra LEE ; Sung Hoon KIM ; Hee Dong CHAE
Author Information

1. Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Publication Type:REVIEW ARTICLE
From:Journal of Menopausal Medicine 2022;28(1):1-8
CountryRepublic of Korea
Language:English
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has impacted the medical, social, and reproductive health of millions of people since its outbreak. The causative virus transmits, reproduces, and manifests through the respiratory tract. COVID-19 can invade any system of the body, including the cardiovascular and endocrine systems, through a secondary immune response. In particular, because the fatality rate is high in those over the age of 50 years, special attention is required during the medical care of this population. However, considering the benefit of therapy and the risk of COVID-19, high-quality evidence regarding individualized management in relation to hormone therapy is still insufficient in the field of gynecology. Furthermore, this review aims to serve as a reference for clinical application by analyzing and summarizing the results of studies reported to date regarding female hormone therapy in the context of the COVID-19 pandemic.